Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
3,139.0
-18.1 (-0.57%)

 

  • STI Straits Times Index
    3,139.0
    -18.1 (-0.57%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,512.5
    -10.9 (-0.72%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    26,192.3
    -1,129.7 (-4.13%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,467.4
    -83.0 (-2.34%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    27,833.3
    285.3 (1.04%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    6,106.4
    4.7 (0.08%)
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 1,058.1M
  • Value: 970.5M
  • Rise: 151
  • Fall: 191
  • Unch: 419

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Thomson Medical0.088+0.003
Jiutian Chemical0.084-0.001
Sembcorp Marine0.104+0.001
Spackman0.005-
Accrelist Ltd0.072+0.015
Oceanus^0.036-
Abundance Intl0.040+0.001
ThaiBev0.655-0.005
SPH1.860+0.010
Rex Intl0.205-

World Indices

World Indices
Name Last Change
Nasdaq 14,837.0 +152.4
HSI 26,192.3 -1129.7
HSCEI 9,355.2 -483.8
Jakarta 6,106.4 +4.7
Nikkei 225 27,833.3 +285.3
SSE Comp 3,467.4 -83.0
Shanghai A 3,634.2 -87.0
Shanghai B 260.4 -3.4
KOSPI 3,224.9 -29.5

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

ASCENDIS PHARMA A/S SPON ADR EACH REP 1 ORD SHS ASCENDIS PHARMA A/S SPONSORED ADR
Updated on 23 Jul 2021 (End of trading day)
Last (USD): 115.660 Change: -1.690 High: 117.720 Remarks: -
Change (%): -1.44 Low: 113.120
Open 117.720 Yesterday's Close 117.35
Buy Price - Sell Price -
Buy Volume (share) - Sell Volume (share) -
Cumulative Volume (share) 220,804 Cumulative Value
Click to show Stock Prices chart

Key Statistics

EPS (USD) a -8.88548 Trailing EPS (USD) e -9.08163 NAV (USD) b 17.5543
PE a - Trailing PE f - Price / NAV b 6.5887
Dividend (USD) d - Cash In Hand (USD) g 10.8246 Issued & Paid-up Shares c 53,750,400
Dividend Yield (%) d - Price / Cash In Hand g 10.685 Treasury Shares h -
Market Cap (M) 6,216.771 Enterprise Value (M) 5,548.936
Piotroski F Score 1 Exchange Code ASND Par Value ( $ ) n.a.
52 Weeks Volatility (%) 31.04 Free Float (%) 95.9
Sector & Industry Health Technology - Pharmaceuticals: Major
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 10 Mar 2021.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 13 Jul 2015.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference ASCENDIS PHARMA A/S SPON ADR EACH REP 1 ORD SHS NASDAQ 6,216.771 - - 6.5887 -
Industry Pharmaceuticals: Major NASDAQ 2,442.648 87.707 92.312 3.4339 1.381
Local Peer ASTRAZENECA SPON ADR EACH REP 0.50 ORD SHS NASDAQ 180,409.933 56.013 45.052 12.5024 1.994
Local Peer SANOFI SPON ADR ECH REP 0.5 ORD SHS NASDAQ 130,768.620 9.316 9.316 1.6964 2.584
Local Peer ROYALTY PHARMA PLC NASDAQ 24,484.827 25.112 25.169 5.0151 0.476
Local Peer VIATRIS INC NASDAQ 16,824.547 - - 0.7857 -
Local Peer REPLIGEN CORP NASDAQ 11,525.553 192.330 144.864 7.4061 -
Local Peer CUREVAC NV NASDAQ 10,087.537 - - - -
Local Peer HUTCHMED (CHINA) LIMITED SPON ADS EACH REPR 5 ORD SHS NASDAQ 6,980.321 - - 16.2981 -
Local Peer LEGEND BIOTECH CORP SPON ADS EACH REP 2 ORD SHS NASDAQ 6,910.517 - - 33.4711 -
Local Peer I MAB SPON ADS EACH REP 2.3 ORD SHS NASDAQ 5,636.741 82.618 82.618 6.5509 -
Local Peer APELLIS PHARMACEUTICALS INC NASDAQ 5,482.637 - - 106.1399 -
Local Peer REATA PHARMACEUTICALS INC NASDAQ 4,697.982 - - 12.7201 -
Local Peer ALLAKOS INC NASDAQ 4,398.072 - - 7.1391 -
Other Local Peers IMMUNITYBIO INC (NASDAQ), SPRINGWORKS THERAPEUTICS INC (NASDAQ), GRIFOLS SA SPON ADR EA REPR 1 ORD EUR0.10 (NASDAQ), CEREVEL THERAPEUTICS HLDGS INC (NASDAQ), KARUNA THERAPEUTICS INC (NASDAQ), TURNING POINT THERAPEUTICS INC (NASDAQ), NEKTAR THERAPEUTICS (NASDAQ), DICERNA PHARMACEUTICALS INC. (NASDAQ), IGM BIOSCIENCES INC (NASDAQ), ATAI LIFE SCIENCES NV (NASDAQ), OPKO HEALTH INC (NASDAQ), ERASCA INC (NASDAQ), ATEA PHARMACEUTICALS INC (NASDAQ), QUANTERIX CORPORATION (NASDAQ), CENTESSA PHARMACEUTICALS PLC SPON ADS EACH REPR 1 ORD SHS (NASDAQ), HARMONY BIOSCIENCES HLDGS INC (NASDAQ), Y-MABS THERAPEUTICS INC (NASDAQ), CONNECT BIOPHARMA HLDGS LTD ADS EACH REP ONE ORD SHARE (NASDAQ), DAY ONE BIOPHARMACEUTICALS INC (NASDAQ), NURIX THERAPEUTICS INC (NASDAQ), KRYSTAL BIOTECH INC (NASDAQ), NRX PHARMACEUTICALS INC (NASDAQ), ZEALAND PHARMA AS SPON ADR EACH REP 1 ORD SHS (NASDAQ), REPARE THERAPEUTICS INC (NASDAQ), ARCUTIS BIOTHERAPEUTICS INC (NASDAQ), KRONOS BIO INC (NASDAQ), GENERATION BIO CO (NASDAQ), FORMA THERAPEUTICS HLDGS INC (NASDAQ), SILVERBACK THERAPEUTICS INC (NASDAQ), CULLINAN ONCOLOGY INC (NASDAQ), PETIQ INC (NASDAQ), MIND MEDICINE (MINDMED) INC (NASDAQ), OLEMA PHARMACEUTICALS INC (NASDAQ), PHATHOM PHARMACEUTICALS INC (NASDAQ), ESSA PHARMA INC (NASDAQ), KINIKSA PHARMACEUTICALS LTD (NASDAQ), PHIBRO ANIMAL HEALTH CORP (NASDAQ), KINNATE BIOPHARMA INC (NASDAQ), OCULAR THERAPEUTIX INC (NASDAQ), KEROS THERAPEUTICS INC (NASDAQ), ADAGENE INC SPON ADS EACH REP 1.25 ORD SHS (NASDAQ), GH RESEARCH PLC (NASDAQ), IDEAYA BIOSCIENCES INC (NASDAQ), ARCTURUS THERAPEUTICS HOLDINGS INC (NASDAQ), POINT BIOPHARMA GLOBAL INC (NASDAQ), ANNEXON INC (NASDAQ), SUTRO BIOPHARMA INC (NASDAQ), AKERO THERAPEUTICS INC (NASDAQ), CRINETICS PHARMACEUTICALS INC (NASDAQ), CALLIDITAS THERAPEUTICS AB SPON ADS EACH REP 2 ORD SHS (NASDAQ), G1 THERAPEUTICS IN (NASDAQ), PRAXIS PRECISION MEDICINES INC (NASDAQ), ALIGOS THERAPEUTICS INC (NASDAQ), ORIC PHARMACEUTICALS INC (NASDAQ), ACUMEN PHARMACEUTICALS INC (NASDAQ), TALARIS THERAPEUTICS INC (NASDAQ), EVOLUS INC (NASDAQ), CHINOOK THERAPEUTICS INC (NASDAQ), GOSSAMER BIO INC (NASDAQ), VERU INC (NASDAQ), AC IMMUNE SA (NASDAQ), TARSUS PHARMACEUTICALS INC (NASDAQ), KALVISTA PHARMACEUTICALS INC (NASDAQ), WEREWOLF THERAPEUTICS INC (NASDAQ), VACCITECH PLC ADR EACH REPR 1 ORD SH SPON (NASDAQ), TCR2 THERAPEUTICS INC (NASDAQ), ALPHA TEKNOVA INC (NASDAQ), EVELO BIOSCIENCES INC (NASDAQ), APPLIED THERAPEUTICS INC (NASDAQ), ALZAMEND NEURO INC (NASDAQ), NANOBIOTIX S A SPON ADS EACH REP 1 ORD SHS (NASDAQ), MIRUM PHARMACEUTICALS INC (NASDAQ), CLENE INC (NASDAQ), PHARVARIS NV (NASDAQ), SIGA TECHNOLOGIES INC (NASDAQ), BOLT BIOTHERAPEUTICS INC (NASDAQ), INOZYME PHARMA INC (NASDAQ), RELMADA THERAPEUTICS INC (NASDAQ), SPERO THERAPEUTICS INC (NASDAQ), OYSTER POINT PHARMA INC (NASDAQ), AMRYT PHARMA PLC (NEW) SPON ADS EACH REP 5 ORD SHS (NASDAQ), PROVENTION BIO INC (NASDAQ), BEYONDSPRING INC (NASDAQ), BIOMEA FUSION INC (NASDAQ), ORCHARD THERAPEUTICS PLC SPON ADS EACH REPR 1 ORD SHS (NASDAQ), XOMA CORP (NASDAQ), GRITSTONE BIO INC (NASDAQ), CODIAK BIOSCIENCES INC (NASDAQ), ATHENEX INC (NASDAQ), 89BIO INC (NASDAQ), FUSION PHARMACEUTICALS INC (NASDAQ), DURECT CORP (NASDAQ), GAMIDA CELL LTD (NASDAQ), THERATECHNOLOGIES INC (NASDAQ), REDHILL BIOPHARMA LTD SPON ADS EA REPR 10 ORD ILS0.00 (NASDAQ), VECTIVBIO HLDG AG (NASDAQ), ANGION BIOMEDICA CORP (NASDAQ), IMPEL NEUROPHARMA INC (NASDAQ), CLEARSIDE BIOMEDICAL INC (NASDAQ), VERRICA PHARMACEUTICALS INC (NASDAQ), SOL GEL TECHNOLOGIES LTD (NASDAQ), PDS BIOTECHNOLOGY CORPORATION (NASDAQ), VINCERX PHARMA INC (NASDAQ), 180 LIFE SCIENCES CORP (NASDAQ), FULCRUM THERAPEUTICS INC (NASDAQ), ACHILLES THERAPEUTICS PLC ADS EACH REPR 1 SHARE SPON (NASDAQ), CITIUS PHARMACEUTICALS INC (NASDAQ), OVID THERAPEUTICS INC (NASDAQ), MUSTANG BIO INC (NASDAQ), KALEIDO BIOSCIENCES INC (NASDAQ), NEXIMMUNE INC (NASDAQ), IMMUNIC INC (NASDAQ), EYEPOINT PHARMACEUTICALS INC (NASDAQ), TFF PHARMACEUTICALS INC (NASDAQ), GALERA THERAPEUTICS INC (NASDAQ), KALA PHARMACEUTICALS INC (NASDAQ), OSMOTICA PHARMACEUTICALS PLC (NASDAQ), XERIS PHARMACEUTICALS INC (NASDAQ), HOOKIPA PHARMA INC (NASDAQ), RENEO PHARMACEUTICALS INC (NASDAQ), HARROW HEALTH INC (NASDAQ), CHECKPOINT THERAPEUTICS INC (NASDAQ), TRICIDA INC (NASDAQ), OBSEVA SA (NASDAQ), 4D PHARMA PLC SPONS ADR EACH REP 8 ORD SHS (NASDAQ), ONCTERNAL THERAPEUTICS INC (NASDAQ), TYME TECHNOLOGIES INC (NASDAQ), ORPHAZYME A/S SPON ADS REP 1 ORD SHS (NASDAQ), PHASEBIO PHARMACEUTICALS INC (NASDAQ), SATSUMA PHARMACEUTICALS INC (NASDAQ), VTV THERAPEUTICS INC (NASDAQ), CYCLERION THERAPEUTICS INC (NASDAQ), MILESTONE PHARMACEUTICALS INC (NASDAQ), SCPHARMACEUTICALS INC (NASDAQ), ANEBULO PHARMACEUTICALS INC (NASDAQ), AYALA PHARMACEUTICALS INC (NASDAQ), LANTERN PHARMA INC (NASDAQ), ADAMIS PHARMACEUTICALS CORPORATION (NASDAQ), QILIAN INTERNATIONAL HLDG GROUP LTD (NASDAQ), ODONATE THERAPEUTICS INC (NASDAQ), GENPREX INC (NASDAQ), POLYPID LTD (NASDAQ), IMARA INC (NASDAQ), VYNE THERAPEUTICS INC (NASDAQ), ETON PHARMACEUTICALS INC (NASDAQ), LOGICBIO THERAPEUTICS INC (NASDAQ), AQUESTIVE THERAPEUTICS INC (NASDAQ), LIQUIDIA CORPORATION (NASDAQ), NOVAN INC (NASDAQ), ENTERA BIO LTD (NASDAQ), NEUBASE THERAPEUTICS INC (NASDAQ), F-STAR THERAPEUTICS INC (NASDAQ), EYENOVIA INC (NASDAQ), REGENCELL BIOSCIENCE HLDGS LTD (NASDAQ), PROPHASE LABS INC (NASDAQ), GALECTO INC (NASDAQ), MEDIWOUND LTD (NASDAQ), AYTU BIOPHARMA INC (NASDAQ), TEMPEST THERAPEUTICS INC (NASDAQ), AERPIO PHARMACEUTICALS INC (NASDAQ), PROTARA THERAPEUTICS INC (NASDAQ), AILERON THERAPEUTICS INC (NASDAQ), MOLECULIN BIOTECH INC (NASDAQ), ELEDON PHARMACEUTICALS INC (NASDAQ), APREA THERAPEUTICS INC (NASDAQ), YUMANITY THERAPEUTICS INC (NASDAQ), APTORUM GROUP LIMITED (NASDAQ), LYRA THERAPEUTICS INC (NASDAQ), GRAYBUG VISION INC (NASDAQ), PURPLE BIOTECH LTD SPON ADS EACH REP 10 ORD SHS (NASDAQ), CORVUS PHARMACEUTICALS INC (NASDAQ), ADDEX THERAPEUTICS LIMITED SPON ADS EACH REP 6 ORD SHS (NASDAQ), DARE BIOSCIENCE INC (NASDAQ), SYNAPTOGENIX INC (NASDAQ), EDESA BIOTECH INC (NASDAQ), UNIVERSE PHARMACEUTICALS INC (NASDAQ), OCUPHIRE PHARMA INC (NASDAQ), AKARI THERAPEUTICS PLC SPON ADR EACH REPR 100 ORD (NASDAQ), INHIBIKASE THERAPEUTICS INC (NASDAQ), MANNATECH INC (NASDAQ), ALLENA PHARMACEUTICALS INC (NASDAQ), ARIDIS PHARMACEUTICAL INC (NASDAQ), ASSERTIO HOLDINGS INC (NASDAQ), BAUDAX BIO INC (NASDAQ), BRICKELL BIOTECH INC (NASDAQ), ACURX PHARMACEUTICALS INC (NASDAQ), VIRIOS THERAPEUTICS INC (NASDAQ), CNS PHARMACEUTICALS INC (NASDAQ), ADIAL PHARMACEUTICALS INC (NASDAQ), TELIGENT INC NEW (NASDAQ), TREVI THERAPEUTICS INC (NASDAQ), BIONDVAX PHARMACEUTICALS SPON ADS REP 40 ORD SHS (NASDAQ), PAINREFORM LTD (NASDAQ), ACER THERAPEUTICS INC (NASDAQ), REVIVA PHARMACEUTICALS HOLDINGS INC (NASDAQ), PANBELA THERAPEUTICS INC (NASDAQ), NLS PHARMACEUTICS LTD (NASDAQ), HOTH THERAPEUTICS INC (NASDAQ), AVENUE THERAPEUTICS INC (NASDAQ), VALLON PHARMACEUTICALS INC (NASDAQ), PETROS PHARMACEUTICALS INC (NASDAQ), IMMURON LIMITED SPON ADR EACH REPR 40 ORD SHS (NASDAQ), TITAN PHARMACEUTICAL INC (NASDAQ), CHINA SXT PHARMACEUTICALS INC (NASDAQ), VIRPAX PHARMA INC (NASDAQ)
Global Peer JOHNSON & JOHNSON NYSE 452,391.786 30.746 25.462 - 2.316
Global Peer ELI LILLY AND COMPANY NYSE 234,146.198 37.804 38.432 33.9408 1.209
Global Peer PFIZER INC NYSE 233,311.719 24.263 21.036 3.4001 3.651
Global Peer NOVARTIS AG ADR-EACH REPR 1 CHF0.5(REGD) NYSE 222,919.839 27.453 24.785 4.1249 2.105
Global Peer ABBVIE INC NYSE 208,749.542 45.819 41.060 15.2262 4.093
Global Peer MERCK & CO INC NYSE 196,335.932 27.782 27.936 7.2866 3.196
Global Peer NOVO NORDISK A/S ADR-EACH CNV INTO 1 CLASS B DKK1 NYSE 160,859.820 24.963 23.929 17.4014 1.482
Global Peer BRISTOL-MYERS SQUIBB CO NYSE 152,666.776 - - 4.0597 2.705
Global Peer GLAXOSMITHKLINE ADR EACH CNV INTO 2 ORD GBP0.25 NYSE 99,400.838 13.483 14.640 4.8467 5.237
Global Peer WUXI APPTEC HKEx 488,644.646 147.229 102.572 11.6733 0.213
Other Global Peers TAKEDA PHARMACEUTICAL CO LTD SPON ADS EACH REP 0.5 ORD SHS (NYSE), HANSOH PHARMA (HKEx), INNOVENT BIO (HKEx), CANSINOBIO-B (HKEx), SINOPHARM (HKEx), BIOHAVEN PHARMACEUTICAL HLDG CO LTD (NYSE), HUTCHMED (HKEx), ORGANON & CO (NYSE), JUNSHI BIO (HKEx), HYGEIA HEALTH (HKEx), SH PHARMA (HKEx), REMEGEN-B (HKEx), CMS (HKEx), AKESO-B (HKEx), INNOCARE-B (HKEx), BAIYUNSHAN PH (HKEx), SIMCERE PHARMA (HKEx), CHINARES PHARMA (HKEx), EMERGENT BIOSOLUTIONS INC (NYSE), TRAD CHI MED (HKEx), CHINAGRANDPHARM (HKEx), HENLIUS (HKEx), CSTONE PHARMA-B (HKEx), EVEREST MED-B (HKEx), CARSGEN-B (HKEx), SSY GROUP (HKEx), OCUMENSION-B (HKEx), HEPALINK (HKEx), ADC THERAPEUTICS SA (NYSE), ZYMEWORKS INC (NYSE), AMNEAL PHARMACEUTICALS INC (NYSE), ANTENGENE-B (HKEx), UNITED LAB (HKEx), TONGRENTANGCM (HKEx), Kimia Farma Tbk. (IDX), BROOKLYN IMMUNO THERAPEUTICS INC (NYSE American), SCICLONE PHARMA (HKEx), IMMUNOTECH-B (HKEx), CKLIFE SCIENCES (HKEx), ANNOVIS BIO INC (NYSE American), SHINEWAY PHARM (HKEx), ZHAOKE OPHTH-B (HKEx), HUA MEDICINE-B (HKEx), Soho Global Health Tbk. (IDX), IGBB (Bursa), RACE ONCOLOGY LTD (ASX), STARPHARMA HOLDINGS LIMITED (ASX), DAWNRAYS PHARMA (HKEx), PYC THERAPEUTICS LIMITED (ASX), AFT PHARMACEUTICALS LTD (ASX), BSTEAD (Bursa), TOT BIOPHARM-B (HKEx), NAVIDEA BIOPHARMACEUTICALS INC (NYSE American), PHARMA (Bursa), FUSEN PHARM (HKEx), IP (SET), LANNETT CO INC (NYSE), CH BIOTECH SER (HKEx), ZHONGZHIPHARM (HKEx), NOXOPHARM LTD (ASX), RECCE PHARMACEUTICALS LTD (ASX), IX Biopharma (SGX), CRESO PHARMA LTD (ASX), Merck Tbk. (IDX), NEW RAY MEDIC (HKEx), CHARMACY PHAR (HKEx), KOTRA (Bursa), Phapros Tbk. (IDX), PAK FAH YEOW (HKEx), NC HEALTHCARE (HKEx), Hyphens Pharma (SGX), MODERN CHI MED (HKEx), NOVA (Bursa), EXOPHARM LTD (ASX), BIOHLDG (Bursa), AGEX THERAPEUTICS INC (NYSE American), INVION LTD (ASX), NEP INTERLONG (HKEx), WAI YUEN TONG (HKEx), MEDLAB CLINICAL LIMITED (ASX), PALLA PHARMA LTD (ASX), TBG DIAGNOSTICS LTD (ASX), EXTRAWELL PHAR (HKEx), PURAPHARM (HKEx), ONCOSIL MEDICAL LIMITED (ASX), TIMBER PHARMACEUTICALS INC (NYSE American), SANAI HEALTH GP (HKEx), JCT (SET), SUNZEN (Bursa), PHARMAXIS (ASX), ACRUX (ASX), IMMURON LIMITED (ASX), TALI DIGITAL LIMITED (ASX), SUDA PHARMACEUTICALS LTD (ASX), ISLAND PHARMACEUTICALS LTD (ASX), SINOLIFE UTD (HKEx), PASHUN INT'L (HKEx), FIJI KAVA LTD (ASX), CELLMID LIMITED (ASX), FARMAFORCE LTD (ASX), Pharmesis Intl (SGX)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days --5.850
-4.81 %
10 Days --9.140
-7.32 %
20 Days --21.250
-15.52 %
Medium Term Return 3 Months --19.990
-14.74 %
6 Months --43.230
-27.21 %
1 Year --24.010
-17.19 %
Long Term Return 2 Years --0.950
-0.81 %
3 Years -+48.830
+73.07 %
5 Years -+101.590
+722.03 %
Annualised Return Annualised --
+52.40 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 113.120 - 183.980 Change From 1 Year Low +2.540 % Change From 1 Year Low (%) +2.25
Change From 1 Year High -68.320 % Change From 1 Year High (%) -37.13
2 Years Range 90.060 - 183.980 Change From 2 Years Low +25.600 % Change From 2 Years Low (%) +28.43
Change From 2 Years High -68.320 % Change From 2 Years High (%) -37.13
5 Years Range 13.370 - 183.980 Change From 5 Years Low +102.290 % Change From 5 Years Low (%) +765.07
Change From 5 Years High -68.320 % Change From 5 Years High (%) -37.13
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

Ascendis Pharma A/S is a biopharmaceutical company, which engages in the development of drug candidates. It specializes on its TransCon technologies to create prodrugs that provide for the predictable and sustained release of an unmodified parent drug. The company was founded by Jan Moller Mikkelsen, Dirk Vetter, and Harald Rau in September 2006 and is headquartered in Hellerup, Denmark.

Historical Price Data

Date Open High Low Close Volume VWAP
23 Jul 2021 117.720 117.720 113.120 115.660 220,804 -
22 Jul 2021 121.170 122.627 117.350 117.350 120,346 -
21 Jul 2021 122.110 124.140 120.340 122.000 147,128 -
20 Jul 2021 121.580 123.340 120.560 122.110 202,690 -
19 Jul 2021 120.320 123.540 118.020 121.510 218,047 -
16 Jul 2021 123.600 124.940 120.910 121.040 261,541 -
15 Jul 2021 122.040 123.220 120.330 122.770 217,623 -
14 Jul 2021 124.640 124.640 120.320 121.840 126,833 -
13 Jul 2021 124.330 125.430 122.000 124.520 121,979 -
12 Jul 2021 126.000 127.220 123.520 124.800 82,979 -
09 Jul 2021 126.510 126.640 123.020 126.050 90,821 -
08 Jul 2021 125.630 128.100 122.690 124.720 93,700 -
07 Jul 2021 133.390 134.500 125.680 126.680 131,366 -
06 Jul 2021 134.160 134.160 131.190 132.060 81,045 -
02 Jul 2021 135.350 135.350 131.900 133.840 71,914 -
01 Jul 2021 132.290 134.770 131.010 134.500 132,338 -
30 Jun 2021 134.240 134.985 130.590 131.550 195,696 -
29 Jun 2021 136.910 136.983 132.840 134.270 89,825 -
28 Jun 2021 141.040 142.180 136.210 136.910 64,476 -
25 Jun 2021 142.990 143.030 140.000 140.350 181,804 -
24 Jun 2021 138.210 143.750 138.210 142.900 200,192 -
23 Jun 2021 135.646 141.000 135.646 138.770 117,976 -
Summary
Current 2 Weeks
(12 Jul 2021 to 23 Jul 2021)
126.000 127.220 113.120 115.660 1,719,970 -
Previous 2 Weeks
(25 Jun 2021 to 09 Jul 2021)
142.990 143.030 113.120 126.050 1,132,985 -
4 Weeks from
(27 May 2021 to 24 Jun 2021)
134.280 136.210 113.120 142.900 4,562,708 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News fr